Lebrikizumab Improves Atopic Dermatitis in Adult and Adolescent Patients With Skin of Color: 16-Week Results From the ADmirable Study. (2025). SKIN The Journal of Cutaneous Medicine, 9(1), s515. https://doi.org/10.25251/skin.9.supp.515